Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)
NCT ID: NCT02544074
Last Updated: 2025-03-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
69 participants
OBSERVATIONAL
2015-01-31
2024-11-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will analyze the data to learn the correlations between eSAGE and gold standard neuropsychological testing designed to differentiate normal cognition from MCI and early dementia. The investigators will also find out whether the paper (SAGE) and electronic (eSAGE) versions of SAGE could be used interchangeably or not.
Addendum:
The eSAGE was previously validated in an earlier stage of this trial. It was initially designed for tablet use and the exact same test has recently been formatted for smartphone use.
This addendum is being conducted to study the validity of the smartphone eSAGE compared to the tablet eSAGE for cognitive screening.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SAGE for the Early Detection of Cognitive Impairment at Primary Care Provider Visits
NCT04063371
Self-screening of Cognitive Impairment in Primary Care
NCT04019665
Integrating eSAGE With EHR Data Using Machine Learning for the Early Detection and Monitoring of Cognitive Impairment in Individuals
NCT06017505
Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease
NCT03672279
Evaluation of the Effects of Serious Cognitive Games on a Digital Tactile Table for Elderly People with Alzheimer's Disease or Related Disorders
NCT06781645
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will analyze the data to learn the correlations between eSAGE and gold standard neuropsychological testing designed to differentiate normal cognition from MCI and early dementia. The investigators will also find out whether the paper (SAGE) and electronic (eSAGE) versions of SAGE could be used interchangeably or not.
Addendum:
Subjects will be scheduled for a one time visit where they will be administered both the tablet eSAGE and the smartphone eSAGE. eSAGE tablet scores will be compared to eSAGE smartphone scores to determine if the two formats are equivalent to each other.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
eSAGE score of 10
Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 11
Participants who score an 11 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 12
Participants who score a 12 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 13
Participants who score a 13 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 14
Participants who score a 14 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 15
Participants who score a 15 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 16
Participants who score a 16 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 17
Participants who score a 17 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 18
Participants who score a 18 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 19
Participants who score a 19 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 20
Participants who score a 20 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 21
Participants who score a 21 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 22
Participants who score a 22 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 9
Participants who score a 9 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 8
Participants who score an 8 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 6
Participants who score a 6 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 7
Participants who score a 7 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 5
Participants who score a 5 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 4
Participants who score a 4 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 3
Participants who score a 3 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE score of 2
Participants who score a 2 on the eSAGE. Interventions include neuropsychological testing.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
Smartphone eSAGE score of 13
Participants who score a 13 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 14
Participants who score a 14 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 15
Participants who score a 15 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 16
Participants who score a 16 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 17
Participants who score a 17 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 18
Participants who score a 18 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 19
Participants who score a 19 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 20
Participants who score a 20 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 21
Participants who score a 21 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Smartphone eSAGE score of 22
Participants who score a 22 on the smartphone eSAGE. Interventions include neuropsychological testing.
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
neuropsychological testing
standard neuropsychological testing including brief standardized assessments
eSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Vision and hearing sufficient for compliance with tests
Exclusion Criteria
* Intellectual disability
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brain Test, Inc.
INDUSTRY
Ohio State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Douglas Scharre
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Douglas Scharre, M.D.
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Ohio State University
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Scharre DW, Chang SI, Nagaraja HN, Vrettos NE, Bornstein RA. Digitally translated Self-Administered Gerocognitive Examination (eSAGE): relationship with its validated paper version, neuropsychological evaluations, and clinical assessments. Alzheimers Res Ther. 2017 Jun 27;9(1):44. doi: 10.1186/s13195-017-0269-3.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014H0039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.